These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26560413)

  • 41. Innate and adaptive immune responses in contact dermatitis: analogy with infections.
    Freudenberg MA; Esser PR; Jakob T; Galanos C; Martin SF
    G Ital Dermatol Venereol; 2009 Apr; 144(2):173-85. PubMed ID: 19357624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral tolerance to haptens: intestinal epithelial cells from 2,4-dinitrochlorobenzene-fed mice inhibit hapten-specific T cell activation in vitro.
    Galliaerde V; Desvignes C; Peyron E; Kaiserlian D
    Eur J Immunol; 1995 May; 25(5):1385-90. PubMed ID: 7774642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE on mast cells.
    Bryce PJ; Miller ML; Miyajima I; Tsai M; Galli SJ; Oettgen HC
    Novartis Found Symp; 2005; 271():15-24; discussion 24-38, 95-9. PubMed ID: 16605126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skin sensitization: understanding the in vivo situation for the development of reliable in vitro test approaches.
    Aeby P; Python F; Goebel C
    ALTEX; 2007; 24 Spec No():3-5. PubMed ID: 19835043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of resolution of allergic contact dermatitis.
    Gaspari AA
    Am J Contact Dermat; 1996 Dec; 7(4):212-9. PubMed ID: 8955483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epicutaneous immunization with hapten-conjugated protein antigen alleviates contact sensitivity mediated by three different types of effector cells.
    Majewska-Szczepanik M; Strzępa A; Drożyńska I; Motyl S; Banach T; Szczepanik M
    Pharmacol Rep; 2012; 64(4):919-26. PubMed ID: 23087144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A quantitative approach to assess the potency of skin sensitizers in the elicitation phase.
    Ezendam J; Vermeulen JP; de Klerk A; de Jong WH; van Loveren H
    Toxicology; 2012 Sep; 299(1):20-4. PubMed ID: 22564262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunotherapy of allergic contact dermatitis.
    Spiewak R
    Immunotherapy; 2011 Aug; 3(8):979-96. PubMed ID: 21843085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modification and expulsion of keratins by human epidermal keratinocytes upon hapten exposure in vitro.
    Bauer B; Andersson SI; Stenfeldt AL; Simonsson C; Bergstroom J; Ericson MB; Jonsson CA; Broo KS
    Chem Res Toxicol; 2011 May; 24(5):737-43. PubMed ID: 21486064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of phagocytic macrophages in induction of contact hypersensitivity and tolerance by hapten applied to normal and ultraviolet B-irradiated skin.
    Kurimoto I; van Rooijen N; Dijkstra CD; Streilein JW
    Immunology; 1994 Oct; 83(2):281-7. PubMed ID: 7835948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Free radicals in antigen formation: reduction of contact allergic response to hydroperoxides by epidermal treatment with antioxidants.
    Gäfvert E; Nilsson JL; Hagelthorn G; Karlberg AT
    Br J Dermatol; 2002 Apr; 146(4):649-56. PubMed ID: 11966698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells--a screening predictive assay for contact sensitizers.
    Krasteva M; Peguet-Navarro J; Moulon C; Courtellemont P; Redziniak G; Schmitt D
    Clin Exp Allergy; 1996 May; 26(5):563-70. PubMed ID: 8735869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-DNP antibody response after the topical application of DNFB in mice.
    Takahashi C; Nishikawa S; Katsura Y; Izumi T
    Immunology; 1977 Oct; 33(4):589-96. PubMed ID: 303613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of contact sensitivity to a broad variety of allergens with haptenized macrophages.
    von Blomberg-van der Flier M; Scheper RJ; Boerrigter GH; Polak L
    J Invest Dermatol; 1984 Aug; 83(2):91-5. PubMed ID: 6470518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Danger, intracellular signaling, and the orchestration of dendritic cell function in skin sensitization.
    Ainscough JS; Frank Gerberick G; Dearman RJ; Kimber I
    J Immunotoxicol; 2013; 10(3):223-34. PubMed ID: 22954466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contact Hypersensitivity.
    Gaspari AA; Katz SI; Martin SF
    Curr Protoc Immunol; 2016 Apr; 113():4.2.1-4.2.7. PubMed ID: 27038464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GammadeltaT cells regulate the development of hapten-specific CD8+ effector T cells in contact hypersensitivity responses.
    Guan H; Zu G; Slater M; Elmets C; Xu H
    J Invest Dermatol; 2002 Jul; 119(1):137-42. PubMed ID: 12164936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance.
    Riemann H; Schwarz A; Grabbe S; Aragane Y; Luger TA; Wysocka M; Kubin M; Trinchieri G; Schwarz T
    J Immunol; 1996 Mar; 156(5):1799-803. PubMed ID: 8596029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro evaluation of the sensitization potential of weak contact allergens using langerhans-like dendritic cells and autologous T cells.
    Rougier N; Redziniak G; Mougin D; Schmitt D; Vincent C
    Toxicology; 2000 Apr; 145(1):73-82. PubMed ID: 10771133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune responses to environmental antigens that act on the skin: the role of lymphokines in contact dermatitis.
    de Weck AL
    Fed Proc; 1977 Apr; 36(5):1742-7. PubMed ID: 321256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.